Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

332
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
332
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

954
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
954
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

189
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
189
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

3.0K
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
3.0K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LaminA/C-dependent cellular senescence signaling promotes skeletal muscle atrophy and abnormalities in Parkinson's disease.

Cell death & disease·2026
Same author

Real-time monitoring of glycocarrier formation unravels cryptic details in glycosyl transfer.

RSC chemical biology·2026
Same author

The skeletal muscle slow myosin heavy chain regulates mammalian metabolic homeostasis through the NRF2 pathway.

Science advances·2026
Same author

Molecular recognition of substrate intermediate and inhibitors by tryptophanyl-tRNA synthetase from Mycobacterium tuberculosis.

International journal of biological macromolecules·2026
Same author

Bridging Simulation and Sustainability: Laccase Immobilization on Bio-Polymeric Hybrids for Degradation of 17α-Ethinylestradiol in Water Systems.

ACS omega·2026
Same author

Enhancing Cloud-Based Healthcare Security With Quantum-Secure HealthChain: A Quantum Computing and Blockchain Integrated Framework.

Health science reports·2026

Related Experiment Video

Updated: Jan 11, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K

UniGEN-DDI: Computing Drug-Drug Interactions Using a Unified Graph Embedding Network.

Somnath Mondal, Debarghya Datta, Soumajit Pramanik

    IEEE Transactions on Computational Biology and Bioinformatics
    |November 13, 2025
    PubMed
    Summary

    UniGEN-DDI, a novel computational model, efficiently predicts drug-drug interactions using biochemical data. It identifies previously unknown interactions, enhancing patient safety and treatment efficacy with reduced computational time.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.3K

    Related Experiment Videos

    Last Updated: Jan 11, 2026

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    2.1K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.3K

    Area of Science:

    • Computational chemistry
    • Bioinformatics
    • Pharmacology

    Background:

    • Drug-drug interactions (DDIs) are critical for patient safety and treatment efficacy.
    • Wet lab studies for DDIs are costly and time-consuming.
    • Biochemical data offers a viable alternative for predicting unknown interactions.

    Purpose of the Study:

    • To develop a computational model, UniGEN-DDI, for estimating drug-drug interactions.
    • To leverage biochemical data for efficient and accurate DDI prediction.
    • To reduce the computational time associated with DDI identification.

    Main Methods:

    • Developed UniGEN-DDI, a unified graph embedding network model.
    • Utilized GraphSAGE and Node2Vec for drug feature learning.
    • Compiled drug association data from DrugBank 5.1.0.

    Main Results:

    • UniGEN-DDI demonstrated high prediction accuracy and significant reduction in computational time.
    • The model performed well on equally distributed and non-overlapping datasets.
    • Identified 15 previously unknown DDIs in DrugBank 5.1.0 (75% accuracy in top 20 estimates).

    Conclusions:

    • UniGEN-DDI is an efficient and accurate computational tool for DDI prediction.
    • The model successfully identifies novel drug interactions, aiding in drug safety and discovery.
    • UniGEN-DDI offers a valuable alternative to traditional wet lab methods for DDI studies.